Bioactives for cholesterol lowering: targeting of cholesterol absorption pathways

Area of Science:

• Biochemistry
• Cardiovascular Science
• Pharmacology

Background:

• Serum cholesterol levels are strongly linked to coronary heart disease (CHD).
• Statins, which inhibit cholesterol synthesis, effectively reduce cardiovascular events.
• Cholesterol absorption in the gastrointestinal tract significantly impacts body cholesterol levels.

Purpose of the Study:

• To explore the potential benefits of targeting key proteins involved in cholesterol absorption and biosynthesis.
• To identify novel therapeutic targets beyond statins for managing cholesterol levels and cardiovascular risk.

Main Methods:

• Review of existing literature on cholesterol metabolism, absorption, and biosynthesis pathways.
• Discussion of naturally occurring compounds (bioactives) affecting cholesterol absorption, such as plant sterols.
• Identification and discussion of specific protein targets, including cholesterol esterase and Niemann-Pick C1-like 1 protein (NPC1L1).

Main Results:

• While mechanisms are not fully elucidated, targeting cholesterol absorption pathways shows promise.
• Plant sterols demonstrate an influence on cholesterol absorption processes.
• Cholesterol esterase and NPC1L1 are identified as significant targets for therapeutic intervention.

Conclusions:

• Inhibiting cholesterol absorption presents a viable strategy for reducing cardiovascular events.
• Targeting specific proteins like cholesterol esterase and NPC1L1 may offer new therapeutic avenues for cholesterol management.
• Further research into the mechanisms of cholesterol absorption and the efficacy of targeting these proteins is warranted.